JOHN E. KAO - 18 Mar 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Issuer symbol
ALHC
Transactions as of
18 Mar 2025
Net transactions value
-$1,024,371
Form type
4
Filing time
19 Mar 2025, 21:48:45 UTC
Previous filing
17 Mar 2025
Next filing
28 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale $465,083 -27,535 -0.55% $16.89 4,991,717 18 Mar 2025 Direct F1, F2
transaction ALHC Common Stock Sale $351,458 -21,846 -0.44% $16.09 4,969,871 19 Mar 2025 Direct F3, F4
transaction ALHC Common Stock Sale $207,830 -12,255 -0.25% $16.96 4,957,616 19 Mar 2025 Direct F3, F5
holding ALHC Common Stock 2,093,100 18 Mar 2025 See Footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
F4 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F5 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F6 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.